Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer.
Sci Rep. 2020 Oct 29;10(1):18605. doi: 10.1038/s41598-020-75625-1.
Sci Rep. 2020.
PMID: 33122723
Free PMC article.
Structural investigation of CDCA3-Cdh1 protein-protein interactions using in vitro studies and molecular dynamics simulation.
Barbhuiya TK, Fisher M, Boittier ED, Bolderson E, O'Byrne KJ, Richard DJ, Adams MN, Gandhi NS.
Barbhuiya TK, et al.
Protein Sci. 2023 Mar;32(3):e4572. doi: 10.1002/pro.4572.
Protein Sci. 2023.
PMID: 36691744
Free PMC article.
CDCA3 is an intrinsically disordered protein and contains both C-terminal KEN box and D-box recognition motifs, enabling binding to Cdh1. ...We identified the role of H-bonds, hydrophobic and ionic interactions across the CDCA3 ABBA-like motif in the linker region between …
CDCA3 is an intrinsically disordered protein and contains both C-terminal KEN box and D-box recognition motifs, enabling binding to C …
Item in Clipboard
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer.
O'Byrne KJ, Thomas AL, Sharma RA, DeCatris M, Shields F, Beare S, Steward WP.
O'Byrne KJ, et al.
Br J Cancer. 2002 Jul 1;87(1):15-20. doi: 10.1038/sj.bjc.6600344.
Br J Cancer. 2002.
PMID: 12085249
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite